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Abstract
The RecQ family of DNA helicases is highly conserved in evolution from bacteria to humans. Of the ﬁve
known human RecQ family members, three (BLM, WRN and RECQ4, which cause Bloom’s syndrome,
Werner’s syndrome and Rothmund–Thomson syndrome respectively) aremutated in distinct clinical disorders
associated with cancer predisposition and/or premature aging. BLM forms part of a multienzyme complex
including topoisomerase IIIα, replication protein A and a newly identiﬁed factor called BLAP75. Together,
these proteins play a role in the resolution of DNA structures that arise during the process of homologous
recombination repair. In the absence of BLM, cells show genomic instability and a high incidence of sister-
chromatid exchanges. In addition to a DNA structure-speciﬁc helicase activity, BLM also catalyses Holliday-
junction branch migration and the annealing of complementary single-stranded DNA molecules.
Introduction
BS (Bloom’s syndrome) is an autosomal recessive disorder
characterized by growth retardation, sunlight sensitivity and
a predisposition to the development of cancer [1]. At the
cellular level, BS is associated with inherent genomic instab-
ility. In comparison with cells isolated from unaffected indi-
viduals, BS cells show an elevated frequency of several types
of chromosomal aberrations, including breaks, quadriradials
and translocations [1–3]. The hallmark feature, which is suffi-
ciently specific to BS cells to be used in the molecular diag-
nosis of the disorder, is an approx. 10-fold elevation in the
frequency of SCEs (sister-chromatid exchanges) [4].
BLM (the BS gene product) is one of five RecQ heli-
case family members expressed in human cells [2,3]. The
RecQ family is highly conserved in evolution from bacte-
ria to humans, particularly in the centrally-located helicase
domain that contains seven characteristic sequence motifs.
BLM, incommonwithEscherichia coliRecQand itsSaccharo-
myces cerevisiae orthologue, Sgs1p, contains two additional
conserved domains. These domains, which are located C-ter-
minal to the helicase domain, are the RQC (RecQ C-
terminal) domain and the HRDC (helicase and RNAse D
C-terminal) domain. Biochemical and structural analyses
have indicated that the RQC and HRDC domains probably
function as auxiliary DNA-binding sites [5–7].
BLM interacts physically and functionally with a number
of other nuclear factors in human cells. Most notably, BLM
binds directly to topoisomerase IIIα, to the RAD51 recombi-
nase, and to RPA [replication protein A, the major ssDNA
(single-stranded DNA)-binding protein in human cells]
[8–10]. Significantly, these interactions are conserved in
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evolution; for example, Sgs1p forms a complex with yeast
Top3p (topoisomerase III protein) and Rad51p [10,11].
The functional significance of these interactions has been
highlighted by the fact that RPA strongly stimulates BLM
helicase activity and, in turn, BLM stimulates topoisomerase
IIIα to relax negatively-supercoiled DNA [8,12].
Recently, a functionally important binding partner of
RecQ helicases was identified independently in both yeast
and human cells. In yeast, large-scale genetic screens identi-
fied RMI1 (NCE4) as a gene that interacts genetically with
SGS1 and, when mutated, produces a phenotype very similar
to that of top3 strains [13,14]. Subsequent work indicated
that Sgs1p, Top3p and Rmi1p form a complex in yeast cells
[13,14]. The human Rmi1 orthologue, named BLAP75, was
identified as a protein that co-immunoprecipitates with BLM
[15]. Crucially, it was shown that siRNA (small interfering
RNA)-mediated depletion of cellular BLAP75 led to an
increase in SCEs, indicating a functional overlap between
BLM and BLAP75.
BLM is a DNA structure-speciﬁc helicase
In the cases where they have been analysed, RecQ heli-
cases catalyseDNAunwinding, i.e. the separation of the com-
plementary strands of duplex DNA. As with most helicases,
RecQ family proteins translocate unidirectionally along
DNA (3′ → 5′ for RecQ proteins), which is defined by the
orientation of the strand to which the enzyme is bound, not
the direction of displacement of the complementary strand
[16].
One striking feature of RecQ helicases is their ability
to recognize and unwind a wide variety of different DNA
structures (Figure 1). In the case of BLM, this includes
forked duplexes, synthetic four-way junctions that mimic the
Holliday-junction recombination-intermediate, and blunt-
ended duplexes with an internal ‘bubble’ of non-comple-
mentary sequence [17]. Interestingly, a fully double-stranded,
C©2005 Biochemical Society
The Nucleus and Gene Expression 1457
Figure 1 Examples of the range of DNA structures that can be unwound by the BLM helicase
(A) 3′-Tailed duplex, (B) ‘bubble’ substrate, (C) forked duplex, (D) synthetic 4-way (Holliday) junction, (E) synthetic
displacement loop, (F) G-quadruplex structure.
blunt-ended structure is not a substrate. BLM, like other
RecQ helicases, also shows a preference for unwinding G-
quadruplex DNA [18]. G-quadruplexes are highly stable,
non-B-form DNA structures that can form in guanine-
rich DNA sequences [19]. The functional significance of
G-quadruplex unwinding by BLM remains unknown, but
a possible role in disruption of telomeric quadruplexes is
suggested by the fact that BLM and other RecQ helicases are
known to influence telomere stability under certain circum-
stances [2,3]. As far as we are aware, RecQ helicases are
unique among helicases in being able to disrupt G-quad-
ruplexes efficiently.
BLM catalyses DNA strand annealing
BLM utilizes the energy derived from the hydrolysis of
ATP to catalyse DNA strand separation. During an analysis
of the effects of varying BLM concentration on the ex-
tent of DNA unwinding, we consistently observed that high
concentrations of BLMwere apparently less active than were
lower BLM concentrations. As a result, when the level of the
unwound reaction product was plotted as a function of
BLM concentration, a pronounced ‘bell-shaped’ curve was
generated (Figure 2A). We considered it possible that this
effect reflected a propensity of BLM to aggregate at high
concentrations. However, an alternative explanation for the
reappearance of the duplex DNA substrate in reactions
containing high concentrations of BLM (Figure 2A) was that
BLM could catalyse the ‘reverse’ reaction to that of a helicase;
namely, the annealing of the complementary ssDNA reaction
products. To analyse this directly, we incubated various
concentrations ofBLMwith the twopartially complementary
ssDNAs (unannealed) used inFigure 2(A) to create the forked
duplex substrate. As indicated in Figure 2(B), there was a
BLM concentration-dependent increase in the annealing of
the ssDNA to form a forked duplex. This DNA strand-
Figure 2 BLM catalyses ssDNA annealing
(A) Effect of increasing BLM concentration on the conversion of a forked
duplex to ssDNA (as indicated on the left). Data are quantiﬁed in the
panel on the right. (B) BLM promotes annealing of complementary
ssDNA. Left panel shows a BLM concentration-dependent increase
in the level of annealed forked-duplex-DNA. Right panel shows that
truncation of the C-terminal domain of BLM by 127 amino acids to
create BLM-(1–1290) inactivates the strand-annealing function.
annealing activity of BLM is ATP-independent and can be
blocked by ssDNA-binding proteins such as RPA [20].
As part of an analysis of the domains within BLM that
are required for the different enzymatic functions of the
protein,wehave shown that theC-terminal domainofBLMis
essential for ssDNA annealing. For example, BLM-(1–1290)
protein, which lacks the C-terminal 127 amino acids of BLM,
is unable to catalyse strand annealing (Figure 2B). Additional
analyses identified a 50-amino-acid region of BLM between
residues 1290 and 1350 as being essential for promoting
strand annealing [20]. At this stage, we do not understand the
precise mechanism by which this activity of BLM is effected.
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The C-terminal truncation of BLM probably influences the
integrity of the HRDC domain, which is predicted to be a
DNA-binding motif in BLM. Two obvious models for the
mechanism of strand annealing are: (i) that BLM brings two
ssDNA molecules into close proximity via protein–protein
interactions, with each BLM protomer containing a ssDNA
species bound via its HRDC domain; or (ii) that through
making specificDNA contacts on each of the ssDNA species,
BLM could limit or neutralize charge repulsion and hence
facilitate base-pairing. Further work is required to assess
whether either of these models is correct.
BLM catalyses a novel mechanism for
resolution of recombination intermediates
The hallmark feature of BS cells is an unusually high
frequency of SCEs [4]. These apparently reciprocal exchanges
arise primarily as part of homologous recombination events
that occur during repair of DNA damage arising in the S or
G2 phases of the cell cycle. This, together with many other
strands of evidence, such as the finding that BLM interacts
with the RAD51 recombinase and the RAD51 paralogue,
RAD51D [10,21], indicates that BLM somehow influences
recombination reactions.
Our group has focused on the idea that the combination of
a RecQ helicase and a type IA topoisomerase (topoisomerase
IIIα in humans) is involved in resolution of recombination
intermediates that contain Holliday junctions. It has long
been considered whether topoisomerases might catalyse
Holliday-junction resolution via their ability to cut DNA
strands and pass other strands through the break. Never-
theless, we and others were unsuccessful in our attempts
to demonstrate any selective cleavage of Holliday-junction
cross-overs by topoisomerase III enzymes. Many models of
recombination involve the processing ofDNA lesions in such
a way as to generate a so-called double Holliday junction,
in which two junctions lie in relatively close proximity to
one another. One proposal set out previously [22] was that
a helicase could migrate these junctions towards one another
to form a single intertwined species called a hemicatenane
and that topoisomerase III would ‘resolve’ this by ss passage
(decatenation) to generate recombinant products (Figure 3).
The beauty of this model is that it avoids any formation of so-
called cross-over recombinant products, which are visualized
cytologically as SCEs, and hence would fit neatly with a role
for BLM in suppression of SCE formation.
Recently, we provided direct experimental evidence for the
above model in demonstrating that BLM and topoisomer-
ase IIIα catalyse a novel reaction for the resolution of double
Holliday junctions, termed Holliday junction dissolution
[23]. This reaction requires the hydrolysis of ATP by BLM
and the active site tyrosine residue of topoisomerase IIIα.
Although the full details of the reaction mechanism under-
lying junction dissolution remain to be elucidated, the
reaction gives rise exclusively to non-cross-over products,
as predicted from the hemicatenane model (Figure 3) and
the role of BLM as a suppressor of SCEs. In addition to the
Figure 3 Model for the resolution of double Holliday junctions
without crossing-over
The two recombining molecules are coloured grey and black. The double
Holliday junction (top) is converted by branch migration of the junctions
to a hemicatenane (middle). The hemicatenane is the substrate for the
ssDNA decatenation (strand passage) activity of topoisomerase III.
The products (bottom) are resolved DNAmolecules with no crossing-over
of the ﬂanking DNA. See text for details.
helicase domain, we have shown that the HRDC domain of
BLM is essential for dissolution. As part of these studies, we
identified Lys1270, which is predicted to contact DNA on the
DNA-binding face of theHRDCdomain, as being important
for efficient dissolution [24].
In summary, BLM forms part of a multienzyme complex
that appears to play roles both in the disruption of alternative
DNA structures, such as quadruplexes, and in the resolution
of DNA intermediates that arise during homologous-re-
combination reactions. Given the similarity between these
recombination intermediates and DNA structures that are
predicted to arise during the late stages of DNA replication
where two forks converge, it will be interesting to analyse
whether BLM and topoisomerase IIIα also play a role in
resolution of replication structures. Another new challenge is
to define the biochemical role of the BLAP75 subunit of the
BLM complex.
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